EUVIMEDEUVIMED entdecken
Open Access

Nanoparticle-assisted targeting of heart lesions with cardiac myofibroblasts: Combined gene and cell therapy

Miriam Schiffer, Kevin Wagner, Esther Carls, Julia Nicke, Michael Hesse, Raluca M Fratila, Staffan Hildebrand, Dietmar Eberbeck, Timo Mohr, Mona Malek Mohammadi, Jesus Martinez de la Fuente, Bernd K Fleischmann und 1 weitere

Theranostics · 18.03.2025 · 15 (10) · 4287-4307

DOI: 10.7150/thno.103816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 18.03.2025. Verfasst von Miriam Schiffer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology I, Medical Faculty, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany. Hauptthemen laut MEDLINE: Myofibroblasts, Myocardial Infarction, Cell- and Tissue-Based Therapy, Genetic Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

The cardiac scar is an area rich in collagen. It is populated by myofibroblasts and lacks Connexin 43 expressing cardiomyocytes. Myocardial infarctions have so far proven little amenable to gene- and cell-based therapeutic interventions. Our aim was to establish an experimental approach with translational potential for effective cell-based gene therapy of the cardiac scar.

Methods

We have developed a targeting strategy for myocardial infarctions by grafting ex vivo lentivirus-transduced and magnetic nanoparticle-loaded embryonic cardiac myofibroblasts into mouse hearts with magnetic steering.

Results

Our approach yielded highly efficient targeting and cell grafting into the cardiac scar. Engraftment rates of myofibroblasts proved very high (30% of injected cells) due to cell proliferation and a low apoptosis rate. We also demonstrate that grafting lentivirus-transduced Connexin 43 overexpressing myofibroblasts into the lesion resulted in increased Connexin 43 protein content and strong protection against ventricular arrhythmias in vivo, as their incidence was reduced by ~ 50% at 2- and 8 weeks after myocardial infarction.

Conclusion

The combination of ex vivo gene and in vivo cell therapy, along with magnetic steering of cardiac myofibroblasts, enables, efficient targeting of the cardiac scar and can even modulate its functional properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyofibroblastsMyocardial InfarctionCell- and Tissue-Based TherapyGenetic TherapyNanoparticlesAnimalsMiceConnexin 43Disease Models, AnimalMyocardiumMice, Inbred C57BLLentivirusTreatment Outcome

Stichwörter der Autor:innen

Connexin 43cardiac myofibroblastsgene and cell therapymyocardial infarctionventricular arrhythmias

Substanzen

Connexin 43

Autor:innen und Institutionen

  • Institute of Physiology I, Medical Faculty, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Department of Cardiac Surgery, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Instituto de Nanociencia y Materiales de Aragón, INMA (CSIC-Universidad de Zaragoza), Campus Río Ebro, Edificio CIRCE, despacho 00.070 C/ Mariano Esquillor, s/n - 50018 Zaragoza, Spain.
  • Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0 28029 Madrid, Spain.
  • Institute of Pharmacology and Toxicology, Medical Faculty, University of Bonn, Biomedizinisches Zentrum, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Physikalisch-Technische Bundesanstalt (PTB), Abbestraße 2-12, 10587 Berlin, Germany.

Zitieren

APA

Schiffer, M., Wagner, K., Carls, E., Nicke, J., Hesse, M., Fratila, R. M., Hildebrand, S., Eberbeck, D., Mohr, T., Mohammadi, M. M., de la Fuente, J. M., Fleischmann, B. K., & Roell, W. (2025). Nanoparticle-assisted targeting of heart lesions with cardiac myofibroblasts: Combined gene and cell therapy. Theranostics, 15(10), 4287-4307. https://doi.org/10.7150/thno.103816

Vancouver

Schiffer M, Wagner K, Carls E, Nicke J, Hesse M, Fratila RM, et al. Nanoparticle-assisted targeting of heart lesions with cardiac myofibroblasts: Combined gene and cell therapy. Theranostics. 2025;15(10):4287-4307. doi:10.7150/thno.103816

BibTeX
@article{Schiffer2025,
  author = {Schiffer, Miriam and Wagner, Kevin and Carls, Esther and Nicke, Julia and Hesse, Michael and Fratila, Raluca M and Hildebrand, Staffan and Eberbeck, Dietmar and Mohr, Timo and Mohammadi, Mona Malek and de la Fuente, Jesus Martinez and Fleischmann, Bernd K and Roell, Wilhelm},
  title = {Nanoparticle-assisted targeting of heart lesions with cardiac myofibroblasts: Combined gene and cell therapy},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {4287--4307},
  doi = {10.7150/thno.103816}
}
Kostenlos starten →